Li H, Chen K, Gong L, Qin J, et al. High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial. JAMA Oncol 2025 Jun 26. doi: 10.1001/jamaoncol.2025.1779.
PMID: 40569623